|
Cambrex Corporation - Company Profile Snapshot
| Company Profile: |
Cambrex Corporation |
| Ticker: |
CBM |
| Exchanges: |
NYSE |
| 2008 Sales: |
249,230,000 |
| Major Industry: |
Chemicals |
| Sub Industry: |
Miscellaneous Chemicals |
| Country: |
UNITED STATES |
| Employees: |
856 |
Business Description
Cambrex Corporation. The Group's principal activity is providing technology-enhanced products and services to pharmaceutical companies and generic drug companies. It primarily comprised of the custom development and manufacture of pharmaceutical ingredients derived from organic chemistry. It also provides essential products and services to drug discovery, development and manufacturing processes for human therapeutics. In January 2008, the Group acquired AS ProSyntest, a privately held API research and development company located in Tallinn, Estonia.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
